Exponent's 15min chart triggered MACD Death Cross, KDJ Death Cross Alert.

Based on Exponent's 15-minute chart, a significant technical indicator has been triggered, namely the MACD Death Cross and KDJ Death Cross at 08/28/2025 13:30. This suggests that the stock price has the potential to continue its downward trajectory, as the momentum of the stock price is shifting towards the downside and may further decrease.

Exponent Inc. (NASDAQ: EXPO), a company focused on advanced healthcare solutions, has recently seen its stock price face significant downward pressure. On August 26, 2025, at 11:00 AM, the company's 15-minute chart triggered both a MACD Death Cross and a KDJ Death Cross, indicating a potential continuation of the downward trend [1]. These technical indicators suggest that the stock price has the potential to continue declining in the near term, with the momentum shifting towards the downside.

The MACD (Moving Average Convergence Divergence) is a widely used momentum indicator that helps identify changes in the direction of the stock price. When the MACD line crosses below the signal line, it suggests a potential continuation of the downward trend. Additionally, the KDJ (Kaufman Adaptive Moving Average) indicator has also crossed below the signal line, indicating a shift in momentum towards the downside [2]. These technical indicators, combined with the company's recent financial performance, paint a concerning picture for Exponent Inc.

The stock price has been on a downward trajectory, with a 32% decline over the past year and a 26% fall over the last three years [1]. While the stock has shown a 4.4% increase in the past week, long-term shareholders remain in the red. The company reported a 2.3% drop in earnings per share (EPS) for the last year, which is not as severe as the share price fall but still indicates a lack of earnings growth [1].

The company's CEO is paid less than the median at similar-sized companies, which could be a positive sign of cost control. However, the more critical question is whether the company will grow earnings in the future. Exponent Inc. has faced a total loss of 31% for investors over the last year, including dividends, against a market gain of about 17% [1]. Over the past five years, shareholders have faced an annual loss of 1.4% [1].

Despite these challenges, Exponent Inc. has the potential to rebound if its fundamentals improve. The company is working on innovative healthcare solutions and has a strong cash reserve. However, investors should be cautious and consider the company's financial situation and the potential risks associated with its business model before making investment decisions.

References:
[1] https://finance.yahoo.com/news/exponent-nasdaq-expo-earnings-shareholder-122737565.html
[2] https://www.ainvest.com/news/nuscale-power-chart-signals-bearish-trend-macd-death-cross-bollinger-bands-narrowing-2508/